Tag: preclinical
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034
By Alexandra Saintpierre Published on 04/08/2024 at 8:52 p.m. Photo credit © SunocciPictures (Boursier.com) — The biotechnology…
MaaT Pharma presents promising preclinical data at AACR for MaaT034 aimed at improving patient responses to immunotherapies – 04/08/2024 at 7:30 p.m.
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aimed to Improve Patient Responses to Immunotherapies Lyon, France, April 8, 2024, 7:20 p.m. CET – MaaT Pharma (EURONEXT: MAAT…
Phaxiam therapeutics (formerly erytech): Launch of a new preclinical program
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
OSE Immunotherapeutics presents the latest data on the BiCKI®IL-7, CLEC-1 and OSE-230 preclinical programs in Immuno-Oncology and Immuno-Inflammation At international conferences – 06/15/2023 at 07:30
Nantes, France – June 15, 2023, 7:30 a.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that the latest scientific data has been selected for oral or poster presentations…
Innate Pharma: preclinical data on a new antibody
(CercleFinance.com) – Innate Pharma unveiled this weekend preclinical data concerning a new therapeutic antibody intended for the treatment of B-cell non-Hodgkin’s lymphoma. In preclinical studies, the compound, dubbed IPH6501, induced…
ABIONYX Pharma announces its strategy in ophthalmology and new positive preclinical results as part of the deployment of two innovative platforms: apotherapy and biovectoring – 03/31/2023 at 18:45
• Very promising preclinical results of the apoA-I biovector in an acute inflammation model • Development of so-called “safe corticosteroids” biovectors to limit the side effects of corticosteroids in AMD…
OSE Immunotherapeutics presents the latest preclinical efficacy data of its IL-7 receptor antagonist OSE-127 in acute lymphoblastic leukemia at the 2022 ASH Annual Meeting – 12/12/2022 at 07:30
Nantes, France – December 12, 2022, 7:30 a.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) presented the latest preclinical data on the use of its IL-7 receptor antagonist (IL-7R)…
Histopathological data from the preclinical repeat-dose toxicity study and ex vivo human tissue cross-reactivity analysis support the safety of IPA’s PolyTope® TATX-03, a synergistic antibody cocktail against the.. .
IPA Toxicity Study Confirms Safety of PolyTope® TATX-03 Antibody Cocktail Against COVID-19 Safety assessments of the PolyTope® TATX-03 allowing a request for DNR, carried out in compliance with the standards…
Pherecydes Pharma: positive preclinical study – 06/27/2022 at 08:52
(AOF) – Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced that the results of a preclinical study carried out with…
Lysogene: driven by positive preclinical results
(CercleFinance.com) – Lysogene’s share is supported Thursday on the Paris Stock Exchange by the presentation of positive preliminary preclinical results in the treatment of fragile X syndrome, a rare genetic…
Onxeo: new preclinical data on AsiDNA
(CercleFinance.com) – Onxep rose by more than 4% on the stock market on Wednesday after the publication of data confirming the relevance of the association of its compound AsiDNA with…
Transgene: preclinical results of a virus against cancer – 03/09/2022 at 08:39
(AOF) – Transgene and its Swedish partner BioInvent announce the selection of their abstract (abstract) describing preclinical results obtained with BT-001, a co-developed oncolytic virus, for a poster presentation at…